Or this
PharmAust (PAA) reveals its phase one trial using MPL for MND and ALS has slowed disease progression in 11 out of 12 patients
Ann: Additional Phase 1 data suggest MPL may inhibit MND, page-128
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $69.28M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5099 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 5100 | 1 |
View Market Depth
| Last trade - 09.28am 22/05/2024 (20 minute delay) ? |
| PAA (ASX) Chart |
Day chart unavailable